0

Antidepressants Drugs Market by Disease Type and Geography - Forecast and Analysis 2022-2026

  • Published: Jul 2022
  • Pages: 121
  • SKU: IRTNTR73899
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The antidepressants drugs market share is expected to increase to USD 5.22 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.44%.

This antidepressants drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers antidepressants drugs market segmentations by disease type (major compulsive disorder, obsessive compulsive disorder, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The antidepressants drugs market report also offers information on several market vendors, including AbbVie Inc., Alkermes Public Ltd. Co., Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., H Lundbeck AS, Johnson and Johnson, Lupin Ltd., Luye Pharma Group Ltd., MagVenture AS, Otsuka Holdings Co. Ltd., Pfizer Inc., SK Biopharmaceuticals Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. among others.

What will the Antidepressants Drugs Market Size be During the Forecast Period?

Antidepressants Drugs Market Size

Download the Free Report Sample to Unlock the Antidepressants Drugs Market Size for the Forecast Period and Other Important Statistics

 

Antidepressants Drugs Market: Key Drivers, Trends, and Challenges

The rising prevalence of depression is notably driving the antidepressants drugs market growth, although factors such as social stigma associated with depression and lack of awareness among people may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the antidepressants drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Antidepressants Drugs Market Driver

  • The rising prevalence of depression is one of the key drivers fueling the antidepressants drugs market growth.
  • Depression affects men, women, and children. It is most evident in the childhood, adolescence, or early adulthood stages.
  • Depression cases have increased significantly since 2021 owing to the negative impact of the pandemic on mental health.
  • The most significant predictors of depressive symptoms during the pandemic were low household income, the experience of multiple pandemic-related stressors, and negative impact on health.
  • As per the Lancet study, 76 million additional cases of anxiety disorders and 53 million of MDD were recorded in 2020, due to the COVID-19 pandemic. This represents a 26% and 28% increase in the two disorders, respectively. Such increasing cases of anxiety disorder will drive market growth during the forecast period.

Key Antidepressants Drugs Market Trend

The development and approval of new drugs is one of the key antidepressants drugs market trends propelling the market growth. The increasing incidences of depression have led pharmaceutical vendors to develop the following new antidepressant drugs for approval:

  • In February 2022, AbbVie announced that it had submitted a supplemental New Drug Application (sNDA) for cariprazine (VRAYLAR) to the US FDA for the adjunctive treatment of MDD in patients receiving antidepressant therapy at present. The submission is supported by results from previously announced clinical trials.
  • In June 2021, Alkermes plc announced that the US Food and Drug Administration (FDA) approved LYBALVI (olanzapine and samidorphan) for the treatment of adults with schizophrenia (depressive episode) and for the treatment of adults with bipolar I disorder (depressive episode).

The aforementioned instances of the development and approval of new drugs are anticipated to propel the market growth during the forecast period.

Key Antidepressants Drugs Market Challenge

  • The social stigma associated with depression and lack of awareness among people is one of the factors hampering the antidepressants drugs market growth.
  • Most people do not know what to do about depression even when they find it. People with mental health problems can also experience discrimination in all aspects of their lives.
  • Ignorance of depression can lead to the premature loss of self-dependence, reduced participation in social interactions, and low self-confidence. Stigmas related to depression not only affect the well-being of a person by preventing them from seeking medical help but also affect the volume consumption of the drugs used for the treatment.
  • Inaccurate assumptions may lead to wrong interpretations about the impact of the disease. Stigmas associated with these diseases can have an adverse impact on the social life of caregivers, including family members.

The above-mentioned stigmas will reduce the adoption of new drugs and thereby will challenge the market growth during the forecast period.

This antidepressants drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global antidepressants drugs market as a part of the pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the antidepressants drugs market during the forecast period.

Who are the Major Antidepressants Drugs Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • AbbVie Inc.
  • Alkermes Public Ltd. Co.
  • Bausch Health Companies Inc.
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • H Lundbeck AS
  • Johnson and Johnson
  • Lupin Ltd.
  • Luye Pharma Group Ltd.
  • MagVenture AS
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • SK Biopharmaceuticals Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

 

This statistical study of the antidepressants drugs market encompasses successful business strategies deployed by the key vendors. The antidepressants drugs market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Abbvie.com - The company offers novel, oral, rapid-acting antidepressant drugs such as AGN 241751.
  • Alkermes.com - The company offers antidepressant drugs such as ALKS 5461 for the treatment of the major depressive disorder.
  • Bauschhealth.com - The company offers antidepressants drugs such as Aplenzin for the treatment of major depressive disorder and seasonal affective disorder.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The antidepressants drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Antidepressants Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the antidepressants drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Antidepressants Drugs Market?

Antidepressants Drugs Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

37% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the antidepressants drugs market in North America. Market growth in this region will be slower than the growth of the market in Europe and Asia.

Government initiatives to combat depression will facilitate the antidepressants drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

There was a rise in the depression in the region due to the outbreak of COVID-19. Thus, the increasing cases of depression since the pandemic will lead to the approval of new antidepressant drugs in the region. Thereby, it is anticipated that the market in focus will grow positively during the forecast period.

What are the Revenue-generating Disease Type Segments in the Antidepressants Drugs Market?

Antidepressants Drugs Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The antidepressants drugs market share growth by the major compulsive disorder segment will be significant during the forecast period. Major compulsive disorder is diagnosed when an individual has a persistently low or depressed mood, anhedonia or decreased interest in pleasurable activities, and others. In 2008, major depressive disorder (MDD) has been ranked as the third cause of the burden of disease worldwide by World Health Organization (WHO), which has projected that this disease will rank first by 2030. However, FDA-approved medications for the treatment of MDD. Such an increase in major depressive disorder will drive the market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the antidepressants drugs market size and actionable market insights on post COVID-19 impact on each segment.

Similar Reports:

 

Antidepressants Drugs Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 5.44%

Market growth 2022-2026

$ 5.22 billion

Market structure

Fragmented

YoY growth (%)

4.29

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key consumer countries

US, Canada, Greece, China, and India

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

AbbVie Inc., Alkermes Public Ltd. Co., Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., H Lundbeck AS, Johnson and Johnson, Lupin Ltd., Luye Pharma Group Ltd., MagVenture AS, Otsuka Holdings Co. Ltd., Pfizer Inc., SK Biopharmaceuticals Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Antidepressants Drugs Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive antidepressants drugs market growth during the next five years
  • Precise estimation of the antidepressants drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the antidepressants drugs industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of antidepressants drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Disease Type

    • 5.1 Market segments
      • Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
    • 5.2 Comparison by Disease Type
      • Exhibit 26: Chart on Comparison by Disease Type
      • Exhibit 27: Data Table on Comparison by Disease Type
    • 5.3 Major depressive disorder - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Major depressive disorder - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Major depressive disorder - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Major depressive disorder - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Major depressive disorder - Year-over-year growth 2021-2026 (%)
    • 5.4 Obsessive compulsive disorder - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Obsessive compulsive disorder - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Obsessive compulsive disorder - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Obsessive compulsive disorder - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Obsessive compulsive disorder - Year-over-year growth 2021-2026 (%)
    • 5.5 Others - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.6 Market opportunity by Disease Type
      • Exhibit 40: Market opportunity by Disease Type ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 42: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 44: Chart on Geographic comparison
      • Exhibit 45: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Greece - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Greece - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Greece - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Greece - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Greece - Year-over-year growth 2021-2026 (%)
    • 7.9 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.10 Canada - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.11 India - Market size and forecast 2021-2026
      • Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 82: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 85: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 86: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 87: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 88: Matrix on vendor position and classification
            • 10.3 AbbVie Inc.
              • Exhibit 89: AbbVie Inc. - Overview
              • Exhibit 90: AbbVie Inc. - Product / Service
              • Exhibit 91: AbbVie Inc. - Key offerings
            • 10.4 Alkermes Public Ltd. Co.
              • Exhibit 92: Alkermes Public Ltd. Co. - Overview
              • Exhibit 93: Alkermes Public Ltd. Co. - Product / Service
              • Exhibit 94: Alkermes Public Ltd. Co. - Key news
              • Exhibit 95: Alkermes Public Ltd. Co. - Key offerings
            • 10.5 Bausch Health Companies Inc.
              • Exhibit 96: Bausch Health Companies Inc. - Overview
              • Exhibit 97: Bausch Health Companies Inc. - Business segments
              • Exhibit 98: Bausch Health Companies Inc. - Key news
              • Exhibit 99: Bausch Health Companies Inc. - Key offerings
              • Exhibit 100: Bausch Health Companies Inc. - Segment focus
            • 10.6 Eli Lilly and Co.
              • Exhibit 101: Eli Lilly and Co. - Overview
              • Exhibit 102: Eli Lilly and Co. - Product / Service
              • Exhibit 103: Eli Lilly and Co. - Key offerings
            • 10.7 F. Hoffmann La Roche Ltd.
              • Exhibit 104: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 105: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 106: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 107: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 108: F. Hoffmann La Roche Ltd. - Segment focus
            • 10.8 H Lundbeck AS
              • Exhibit 109: H Lundbeck AS - Overview
              • Exhibit 110: H Lundbeck AS - Product / Service
              • Exhibit 111: H Lundbeck AS - Key offerings
            • 10.9 Johnson and Johnson
              • Exhibit 112: Johnson and Johnson - Overview
              • Exhibit 113: Johnson and Johnson - Business segments
              • Exhibit 114: Johnson and Johnson - Key news
              • Exhibit 115: Johnson and Johnson - Key offerings
              • Exhibit 116: Johnson and Johnson - Segment focus
            • 10.10 Lupin Ltd.
              • Exhibit 117: Lupin Ltd. - Overview
              • Exhibit 118: Lupin Ltd. - Product / Service
              • Exhibit 119: Lupin Ltd. - Key news
              • Exhibit 120: Lupin Ltd. - Key offerings
            • 10.11 MagVenture AS
              • Exhibit 121: MagVenture AS - Overview
              • Exhibit 122: MagVenture AS - Product / Service
              • Exhibit 123: MagVenture AS - Key offerings
            • 10.12 Viatris Inc.
              • Exhibit 124: Viatris Inc. - Overview
              • Exhibit 125: Viatris Inc. - Business segments
              • Exhibit 126: Viatris Inc. - Key offerings
              • Exhibit 127: Viatris Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 128: Inclusions checklist
                • Exhibit 129: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 130: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 131: Research methodology
                • Exhibit 132: Validation techniques employed for market sizing
                • Exhibit 133: Information sources
              • 11.5 List of abbreviations
                • Exhibit 134: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Antidepressants Drugs Market market growth will increase by $5.22 bn during 2022-2026.
              The antidepressants drugs market market is expected to grow at a CAGR of 5.44% during 2022-2026.
              Technavio has segmented the antidepressants drugs market market by other 1 (Major compulsive disorder, Obsessive compulsive disorder, and Others) and geography (North America, Europe, Asia, and Rest of World (ROW)).
              AbbVie Inc., Alkermes Public Ltd. Co., Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., H Lundbeck AS, Johnson and Johnson, Lupin Ltd., Luye Pharma Group Ltd., MagVenture AS, Otsuka Holdings Co. Ltd., Pfizer Inc., SK Biopharmaceuticals Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc. are a few of the key vendors in the antidepressants drugs market market.
              North America will register the highest growth rate of 37% among the other regions. Therefore, the antidepressants drugs market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the antidepressants drugs market market growth are:
              • Rising prevalence of depression
              • Development and approval of new drugs
              The antidepressants drugs market market vendors should focus on grabbing business opportunities from the major compulsive disorder segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>